The APPRAISE APixaban for PRevention of Acute Ischemic Safety Events brand, founded in 2007 (United States), from 496 sister brands and 17477 competing brands. APPRAISE APixaban for PRevention of Acute Ischemic Safety Events is a brand of BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York. APPRAISE APixaban for PRevention of Acute Ischemic Safety Events belongs to the Drug Manufacturers business sector.
Share price and profitability of the share BRISTOL-MYERS SQUIBB COMPANY (APPRAISE APixaban for PRevention of Acute Ischemic Safety Events)
Buy BRISTOL-MYERS SQUIBB COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(APPRAISE APixaban for PRevention of Acute Ischemic Safety Events)
over 5 years*
USD 51.16
Stock market history BRISTOL-MYERS SQUIBB COMPANY (APPRAISE APixaban for PRevention of Acute Ischemic Safety Events)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
